MMV, deepmirror launch free AI drug discovery platform
MMV and deepmirror have launched a free AI platform for eligible global health researchers working on malaria, TB and neglected tropical diseases
Pipeline reality check:
If less than 1% of leads close, what are we really optimizing for?
A 22-minute executive breakdown of what separates converting campaigns from stalled pipeline.
1 May 2026 REGISTER NOW
Pipeline reality check:
If less than 1% of leads close, what are we really optimizing for?
A 22-minute executive breakdown of what separates converting campaigns from stalled pipeline.
1 May 2026 REGISTER NOWA COFFEE WITH
Building the blueprint for an AI-native telecoms future
Aaron Boasman-Patel, VP of innovation at TM Forum, on getting competitors to collaborate, why AI-washing is rife and what the Victorian era has to do with satellite networks
TI:TALKS
Pipeline reality check:
If less than 1% of leads close, what are we really optimizing for?
A 22-minute executive breakdown of what separates converting campaigns from stalled pipeline.
1 May 2026 REGISTER NOW
Pipeline reality check:
If less than 1% of leads close, what are we really optimizing for?
A 22-minute executive breakdown of what separates converting campaigns from stalled pipeline.
1 May 2026 REGISTER NOW
